A Randomized Controlled Study of Transcranial Magnetic Stimulation for Postoperative Headache in Patients With Growth Hormone（GH） Pituitary Tumor
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 主要终点
- the improvement of quality of life(QOL)
研究概览
简要总结
Headache is a very common main complaint of patients with GH pituitary tumor, which has seriously affected the normal work and life of patients. Although the current surgery and drugs have a certain effect on patients with headache, the overall effect is not satisfied. However, the use of COX-2 inhibitors, non-steroidal anti-inflammatory drugs and other analgesics are only effective for some patients with headaches, and long-term use has adverse reactions. Therefore, it is necessary to seek new treatments for postoperative headaches in patients with GH pituitary tumors. Transcranial magnetic stimulation (TMS) modulates the excitability of the underlying cerebral cortex by applying a rapidly changing magnetic field on the surface of the scalp. It is a relatively simple and safe method. It is currently approved for treating depression, migraine, obsessive-compulsive disorder, and Alzheimer's disease. Several small clinical studies have proven that rTMS can be used to prevent and treat Headache. Therefore, this study aims to observe the efficacy and safety of TMS in the treatment of postoperative headache in patients with GH pituitary tumors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with GH tumor who have undergone transnasal pituitary tumor resection or craniotomy for pituitary tumor resection in the past (3 months or more), aged between 18 and 60 years old, regardless of gender;
- •Preoperative glucose tolerance test (OGTT) simultaneously determines that the trough value of GH is greater than 1ng/ml, and the level of IGF-1 is greater than the upper limit of the age-sex-matched normal value; ③. Biochemical remission is achieved after surgery, that is, the random GH value is less than 1ng/ml, and the IGF-1 level is within the normal range of age and gender matching; ④. The patient still has headaches after the operation, the duration of each attack is more than 4 hours, and the attack is more than 3 times per month; ⑤. The patient is in a headache attack period; ⑥. A clear consciousness, able to understand and sign an informed consent form.
排除标准
- •Patients who are being treated with somatostatin and bromocriptine;
- •Patients with other intracranial organic diseases;
- •Pregnant women and children who cannot express;
- •Patients with other malignant tumors;
- •Participate in other clinical research in the same period; ⑥. Patients with severe medical complications, such as heart, lung, kidney, liver and other diseases, severe hypertension or poor blood pressure control, hyperglycemia, blood diseases;
- •Those with mental illness who cannot cooperate well with the experiment;
- •Patients with acute infection or open wounds; ⑨. Acetaminophen is contraindicated (hemolytic anemia, severe liver and kidney dysfunction) or allergic to its components; ⑩. Patients with contraindications to transcranial magnetic stimulation: patients or users who have implanted cardiac pacemakers, implantable defibrillators and neurostimulators together; those who have a history of epilepsy; wear electronic products (such as insulin Pumps, Holter, etc.).
研究组 & 干预措施
Simple acetaminophen treatment
Acetaminophen will be taken when patients suffered from headache during the study. No specific dosage and frequency was required for this group as long as the participants record the exact drug usage.
干预措施: Acetaminophen (Drug)
Simple acetaminophen combined with low-frequency rTMS
Apart from acetaminophen usage, low frequency TMS (1HZ) will be used in patients three times a month for 6 months.
干预措施: Transcranial magnetic stimulation (Device)
Simple acetaminophen combined with low-frequency rTMS
Apart from acetaminophen usage, low frequency TMS (1HZ) will be used in patients three times a month for 6 months.
干预措施: Acetaminophen (Drug)
Simple acetaminophen combined with high-frequency rTMS
Apart from acetaminophen usage, high frequency TMS (10HZ) will be used in patients three times a month for 6 months.
干预措施: Transcranial magnetic stimulation (Device)
Simple acetaminophen combined with high-frequency rTMS
Apart from acetaminophen usage, high frequency TMS (10HZ) will be used in patients three times a month for 6 months.
干预措施: Acetaminophen (Drug)
结局指标
主要结局
the improvement of quality of life(QOL)
时间窗: 6 months
Migraine Defect Assessment Questionnaire MIDAS will be used to evaluate QOL. The QOL will be assessed before and after 6 months of intervention and the changes of MIDAS scores will be compared among 3 groups
changes in the degree of headache
时间窗: 6 months
The degree of headache will be measured by the Visual Analog Scale VAS and the scores change before and after 6 months of intervention will be compared among 3 groups
次要结局
- The decrease of using acetaminophen(6 months)